Intracranial Aneurysm Market - By Treatment Type (Endovascular Coiling, Surgical Clipping, Flow Diverters), By End-use (Hospitals, Clinics)

List of Tables

Global Intracranial Aneurysm Market will witness 8.1% CAGR between 2023 and 2032 due to groundbreaking innovations and research focused on detecting aneurysms using novel methodologies.

Advanced imaging techniques and diagnostic tools, including high-resolution imaging modalities like CT angiography and magnetic resonance angiography (MRA), and AI technologies enable early detection and accurate assessment of aneurysms. For instance, in November 2023, At the Radiological Society of North America conference, Tel Aviv University researchers unveiled an AI algorithm capable of identifying previously undetected intracranial aneurysms in CT angiography (CTA) scans. Analyzing 2,617 CTA cases, 127 (4.7%) contained aneurysms. The algorithm highlighted 34 cases as potential missed aneurysms, with subsequent validation by multiple neuroradiologists confirming 23 (67%) as true-positive aneurysms. This discovery reflects a 23% improvement in detection rates, marking a significant advancement in aneurysm identification through AI-based retrospective analysis.

Emerging technologies, such as computational modeling and AI-driven algorithms, bolster precision in identifying aneurysm risk factors. As research continues to unveil innovative detection methods, the intracranial aneurysm market outlook experiences heightened demand for these cutting-edge solutions, revolutionizing intracranial aneurysm diagnosis and patient care.

The overall Intracranial Aneurysm Market is classified based on treatment type, end-user, and region.

Surgical clipping segment will undergo significant development from 2023 to 2032. This traditional technique involves securing an aneurysm with a metal clip to prevent rupture. Despite the advent of endovascular coiling, surgical clipping remains crucial for specific aneurysm types or locations. Neurosurgeons prefer it for complex or wide-necked aneurysms due to its durability. As surgical techniques advance, the intracranial aneurysm market demand for skilled neurosurgeons and specialized tools continues to grow, underscoring the enduring significance of this method in addressing intracranial aneurysms.

Intracranial Aneurysm Market size from the clinics segment will register a noteworthy CAGR from 2023 to 2032. Clinics increasingly emphasize screening programs using advanced imaging modalities like CT angiography and magnetic resonance angiography. Early identification of aneurysms allows for timely intervention, reducing the risk of rupture and related complications. As clinics prioritize comprehensive care and awareness, the intracranial aneurysm market share is set on expansion. Therefore, clinics that ensure better patient outcomes, preventive measures, and efficient diagnostic tools and procedures are on the rise.

Europe intracranial aneurysm market share will demonstrate a commendable CAGR from 2023 to 2032. The region's proactive approach towards neurological disorders fuels the adoption of innovative diagnostic tools and treatment options for aneurysms. With a focus on early detection through cutting-edge imaging technologies and a growing aging population, Europe drives the demand for precise interventions and minimally invasive procedures. As healthcare standards rise, the market witnesses an upsurge in demand for specialized devices and techniques to address intracranial aneurysms, ensuring improved patient care across Europe.

Product Code: 7061

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Base estimates & workings
1.5 Forecast calculations
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global intracranial aneurysm market 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Treatment type trends
- 2.1.4 End-use trends

Chapter 3 Intracranial Aneurysm Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory scenario
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing awareness regarding intracranial aneurysms
  - 3.5.1.2 Growing geriatric population
  - 3.5.1.3 Increasing advances in medical technology
  - 3.5.1.4 Rising incidence of hypertension and lifestyle-related diseases
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 High cost of treatment
  - 3.5.2.2 Limited access to advanced care
3.6 Growth potential analysis
- 3.6.1 By treatment type
- 3.6.2 By end-use
3.7 Future market trends
3.8 Reimbursement scenario
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Intracranial Aneurysm Market Size and Forecast, By Treatment Type, 2018-2032 (USD Million)

5.1 Key trends, by treatment type
5.2 Endovascular coiling
5.3 Surgical clipping
5.4 Flow diverters
5.5 Other treatment types

Chapter 6 Intracranial Aneurysm Market Size and Forecast, By End-use, 2018-2032 (USD Million)

6.1 Key trends, by end-use
6.2 Hospitals
6.3 Clinics
6.4 Other end-users

Chapter 7 Intracranial Aneurysm Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Indonesia
- 7.4.7 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Israel
- 7.6.5 Rest of Middle East & Africa

Chapter 8 Company Profiles

8.1 Medtronic
8.2 Stryker
8.3 MicroPort Scientific Corporation
8.4 Johnson & Johnson Services, Inc.
8.5 MicroVention Inc.
8.6 Integra LifeSciences
8.7 B. Braun Melsungen AG
8.8 Delta Surgical
8.9 Mizuho Medical Co. Ltd.
8.10 Penumbra, Inc.